{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-027312","form_type":"8-K","ticker":"IMCR","cik":"0001671927","company_name":"Immunocore Holdings plc","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.513790+00:00","generated_at":"2026-06-01T09:14:16.434707+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Immunocore shareholders re-elect all directors, approve executive compensation, ratify Deloitte at 2024 AGM","bullets":["Bahija Jallal re-elected with 34.24M for (99.96%); Sir John Bell re-elected with 30.13M for (87.95%).","Advisory say-on-pay passed with 33.62M for (98.07%); shareholders chose 'One Year' frequency (34.21M votes).","Deloitte LLP ratified as U.S. independent auditor for 2024 with 34.26M for (99.99%).","New articles of association adopted as special resolution with 34.25M for (99.99%).","Directors' remuneration report for 2023 approved with 33.72M for (98.44%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-027312","json":"https://secwatch.observer/filing/0001140361-24-027312.json","markdown":"https://secwatch.observer/filing/0001140361-24-027312.md","text":"https://secwatch.observer/filing/0001140361-24-027312.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124027312/0001140361-24-027312-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124027312/ef20029907_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:14:16.434707+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}